drugset / Trial / NCT04317001
Treatment for Cognitive Impairment in Depression
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The proposed study seeks to investigate the effects of modafinil on cognitive function in depression, which holds promise for better treating cognitive impairment in depression, as well as better understand cognitive dysfunction in MDD from a neural rather than diagnostic point of view to better classify and treat these disabling symptoms.
Timeline
- Start
- 2018-12-01
- Primary completion
- 2022-11-30
- Completion
- 2024-11-30
Outcome
Outcome not reported
Stopped: “Researcher leading the study moved institutions study not feasible”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Modafinil | Small molecule | 100 mg | — |